Michael R. Kilbourn - Publications

Affiliations: 
Radiology University of Michigan Medical School, Ann Arbor, MI, United States 
Area:
PET neuroimaging, Parkinson's disease, PET radiochemistry
Website:
http://www2.med.umich.edu/pcdv2/provider/dsp_provprofile.cfm?individual_id=143674&um_department=Radiology

220 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Drake LR, Pham JM, Desmond TJ, Mossine AV, Lee SJ, Kilbourn MR, Koeppe RA, Brooks AF, Scott PJH. Identification of AV-1451 as a Weak, Nonselective Inhibitor of Monoamine Oxidase. Acs Chemical Neuroscience. PMID 31339297 DOI: 10.1021/acschemneuro.9b00326  0.36
2018 Drake LR, Brooks AF, Mufarreh AJ, Pham JM, Koeppe RA, Shao X, Scott PJH, Kilbourn MR. Deuterium Kinetic Isotope Effect Studies of a Potential In Vivo Metabolic Trapping Agent for Monoamine Oxidase-B. Acs Chemical Neuroscience. PMID 30074755 DOI: 10.1021/acschemneuro.8b00219  0.36
2017 Blecha JE, Henderson BD, Hockley BG, VanBrocklin HF, Zubieta JK, DaSilva AF, Kilbourn MR, Koeppe RA, Scott PJH, Shao X. An Updated Synthesis of [(11) C]Carfentanil for Positron Emission Tomography (PET) Imaging of the μ-Opioid Receptor. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 28419528 DOI: 10.1002/jlcr.3513  0.36
2016 Kilbourn MR. PET studies in non-human primates: Choosing drug doses. Nuclear Medicine and Biology. 47: 1-3. PMID 28012346 DOI: 10.1016/j.nucmedbio.2016.12.001  0.48
2016 Scott PJ, Shao X, Desmond TJ, Hockley BG, Sherman P, Quesada CA, Frey KA, Koeppe RA, Kilbourn MR, Bohnen NI. Investigation of Proposed Activity of Clarithromycin at GABAA Receptors Using [(11)C]Flumazenil PET. Acs Medicinal Chemistry Letters. 7: 746-50. PMID 27563397 DOI: 10.1021/acsmedchemlett.5b00435  0.88
2015 Brooks AF, Shao X, Quesada CA, Sherman P, Scott PJ, Kilbourn MR. In Vivo Metabolic Trapping Radiotracers for Imaging Monoamine Oxidase-A and -B Enzymatic Activity. Acs Chemical Neuroscience. PMID 26393369 DOI: 10.1021/acschemneuro.5b00223  0.88
2014 Kilbourn M. Green radiochemistry Nuclear Medicine and Biology. 41: 651-652. PMID 24993372 DOI: 10.1016/j.nucmedbio.2014.04.128  0.88
2014 Fawaz MV, Brooks AF, Rodnick ME, Carpenter GM, Shao X, Desmond TJ, Sherman P, Quesada CA, Hockley BG, Kilbourn MR, Albin RL, Frey KA, Scott PJ. High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection. Acs Chemical Neuroscience. 5: 718-30. PMID 24896980 DOI: 10.1021/cn500103u  0.88
2014 Rodnick ME, Shao X, Kozloff KM, Scott PJ, Kilbourn MR. Carbon-11 labeled cathepsin K inhibitors: syntheses and preliminary in vivo evaluation. Nuclear Medicine and Biology. 41: 384-9. PMID 24637099 DOI: 10.1016/j.nucmedbio.2014.02.004  0.88
2014 Petrou M, Frey KA, Kilbourn MR, Scott PJ, Raffel DM, Bohnen NI, Müller ML, Albin RL, Koeppe RA. In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 396-404. PMID 24481024 DOI: 10.2967/jnumed.113.124792  0.88
2014 Raffel DM, Kilbourn MR, Koeppe RA. Donald M. Wieland, Ph.D Nuclear Medicine and Biology. DOI: 10.1016/j.nucmedbio.2014.11.014  0.88
2014 Kilbourn MR. Radioligands for imaging vesicular monoamine transporters Pet and Spect of Neurobiological Systems. 765-790. DOI: 10.1007/978-3-642-42014-6_27  0.88
2013 Kilbourn MR. PET radioligands for the vesicular transporters for monoamines and acetylcholine Journal of Labelled Compounds and Radiopharmaceuticals. 56: 167-171. PMID 24285322 DOI: 10.1002/jlcr.2998  0.88
2013 Hockley BG, Stewart MN, Sherman P, Quesada C, Kilbourn MR, Albin RL, Scott PJ. (-)-[(18) F]Flubatine: evaluation in rhesus monkeys and a report of the first fully automated radiosynthesis validated for clinical use. Journal of Labelled Compounds & Radiopharmaceuticals. 56: 595-9. PMID 24285235 DOI: 10.1002/jlcr.3069  0.88
2013 Kilbourn MR. Fluorine-for-hydrogen: A strategy for radiolabeling, not a replacement Nuclear Medicine and Biology. 40: 956-958. PMID 24074943 DOI: 10.1016/j.nucmedbio.2013.08.006  0.88
2013 Rodnick ME, Hockley BG, Sherman P, Quesada C, Battle MR, Jackson A, Linder KE, Macholl S, Trigg WJ, Kilbourn MR, Scott PJH. Novel fluorine-18 PET radiotracers based on flumazenil for GABAA imaging in the brain Nuclear Medicine and Biology. 40: 901-905. PMID 23890694 DOI: 10.1016/j.nucmedbio.2013.06.004  0.88
2013 Kilbourn M. Imaging the Vesicular Monoamine Transporter (VMAT2) in Neurodegenerative Diseases Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 20. DOI: 10.1016/B978-0-12-800044-1.00016-7  0.88
2012 Shao X, Carpenter GM, Desmond TJ, Sherman P, Quesada CA, Fawaz M, Brooks AF, Kilbourn MR, Albin RL, Frey KA, Scott PJ. Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles. Acs Medicinal Chemistry Letters. 3: 936-41. PMID 24900410 DOI: 10.1021/ml300216t  0.88
2012 Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MR, Gilman S, Albin RL, Frey KA. Heterogeneity of cholinergic denervation in Parkinson's disease without dementia. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 1609-17. PMID 22569194 DOI: 10.1038/jcbfm.2012.60  0.88
2012 Kilbourn MR. Synthesis of (+)-α-[11C]Dihydrotetrabenazine ([11C]DTBZ) Radiochemical Syntheses: Radiopharmaceuticals For Positron Emission Tomography. 1: 213-219. DOI: 10.1002/9781118140345.ch21  0.88
2012 Scott PJH, Kilbourn MR. Preface Radiochemical Syntheses: Radiopharmaceuticals For Positron Emission Tomography. 1: XIX-XX. DOI: 10.1002/9781118140345  0.88
2011 Bohnen NI, Müller ML, Zarzhevsky N, Koeppe RA, Bogan CW, Kilbourn MR, Frey KA, Albin RL. Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. Brain : a Journal of Neurology. 134: 2358-65. PMID 21653540 DOI: 10.1093/brain/awr139  0.88
2011 Burke JF, Albin RL, Koeppe RA, Giordani B, Kilbourn MR, Gilman S, Frey KA. Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography. Brain : a Journal of Neurology. 134: 1647-57. PMID 21555336 DOI: 10.1093/brain/awr089  0.88
2011 Kilbourn MR, Domino EF. Increased in vivo [11C]raclopride binding to brain dopamine receptors in amphetamine-treated rats. European Journal of Pharmacology. 654: 254-7. PMID 21262223 DOI: 10.1016/j.ejphar.2011.01.008  0.88
2010 Pichika R, Jewett DM, Sherman PS, Traynor JR, Husbands SM, Woods JH, Kilbourn MR. Synthesis and in vivo brain distribution of carbon-11-labeled δ-opioid receptor agonists. Nuclear Medicine and Biology. 37: 989-96. PMID 21055630 DOI: 10.1016/j.nucmedbio.2010.06.002  0.88
2010 Kilbourn MR. Rat pancreas uptake of [11C]dihydrotetrabenazine stereoisomers Nuclear Medicine and Biology. 37: 869-871. PMID 21055616 DOI: 10.1016/j.nucmedbio.2010.06.001  0.88
2010 Coenen HH, Elsinga PH, Iwata R, Kilbourn MR, Pillai MR, Rajan MG, Wagner HN, Zaknun JJ. Fluorine-18 radiopharmaceuticals beyond [18F]FDG for use in oncology and neurosciences. Nuclear Medicine and Biology. 37: 727-40. PMID 20870148 DOI: 10.1016/j.nucmedbio.2010.04.185  0.88
2010 Albin RL, Koeppe RA, Burke JF, Giordani B, Kilbourn MR, Gilman S, Frey KA. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment. Archives of Neurology. 67: 440-6. PMID 20385910 DOI: 10.1001/archneurol.2010.34  0.88
2010 Kilbourn MR, Butch ER, Desmond T, Sherman P, Harris PE, Frey KA. In vivo [11C]dihydrotetrabenazine binding in rat striatum: sensitivity to dopamine concentrations Nuclear Medicine and Biology. 37: 3-8. PMID 20122661 DOI: 10.1016/j.nucmedbio.2009.08.013  0.88
2010 Bohnen NI, Müller MLTM, Kotagal V, Koeppe RA, Kilbourn MR, Albin RL, Frey KA. Reply: Cognition and olfaction in Parkinson's disease Brain. 133: e161. DOI: 10.1093/brain/awq228  0.88
2010 Hefti FF, Kung HF, Kilbourn MR, Carpenter AP, Clark CM, Skovronsky DM. 18F-AV-133: A selective VMAT2-binding radiopharmaceutical for PET imaging of dopaminergic neurons Pet Clinics. 5: 75-82. DOI: 10.1016/j.cpet.2010.02.001  0.88
2009 Choi SR, Golding G, Zhuang Z, Zhang W, Lim N, Hefti F, Benedum TE, Kilbourn MR, Skovronsky D, Kung HF. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1887-94. PMID 19837759 DOI: 10.2967/jnumed.109.065284  0.88
2009 Kilbourn MR, Hockley B, Lee L, Sherman P, Quesada C, Frey KA, Koeppe RA. Positron emission tomography imaging of (2R,3R)-5-[18F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter Nuclear Medicine and Biology. 36: 489-493. PMID 19520289 DOI: 10.1016/j.nucmedbio.2009.02.007  0.88
2009 Joshi AD, Koeppe RA, Fessler JA, Kilbourn MR. Signal separation and parameter estimation in noninvasive dual-tracer PET scans using reference-region approaches Journal of Cerebral Blood Flow and Metabolism. 29: 1346-1357. PMID 19401708 DOI: 10.1038/jcbfm.2009.53  0.88
2009 Albin RL, Koeppe RA, Wernette K, Zhuang W, Nichols T, Kilbourn MR, Frey KA. Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome. Neurology. 72: 1390-6. PMID 19380698 DOI: 10.1212/WNL.0b013e3181a187dd  0.88
2009 Eckelman WC, Kilbourn MR, Mathis CA. Specific to nonspecific binding in radiopharmaceutical studies: it's not so simple as it seems! Nuclear Medicine and Biology. 36: 235-237. PMID 19324268 DOI: 10.1016/j.nucmedbio.2008.12.002  0.88
2009 Shao X, Kilbourn MR. A simple modification of GE tracerlab FX C Pro for rapid sequential preparation of [11C]carfentanil and [11C]raclopride Applied Radiation and Isotopes. 67: 602-605. PMID 19162491 DOI: 10.1016/j.apradiso.2008.12.013  0.88
2009 Scott PJ, Hockley BG, Kung HF, Manchanda R, Zhang W, Kilbourn MR. Studies into radiolytic decomposition of fluorine-18 labeled radiopharmaceuticals for positron emission tomography. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 67: 88-94. PMID 18951032 DOI: 10.1016/j.apradiso.2008.08.015  0.88
2009 Hockley BG, Scott PJH, Kilbourn MR. Solid-Phase Radiochemistry Linker Strategies in Solid-Phase Organic Synthesis. 577-587. DOI: 10.1002/9780470749043.ch22  0.88
2009 Weaver AS, Su YP, Begun DL, Zade RT, Alford AI, Hankenson KD, Kreider JM, Ablowitz SA, Kilbourn MR, Goldstein SA. Systemic mesenchymal stem cell delivery and axial mechanical stimulation accelerate fracture healing Proceedings of the Asme Summer Bioengineering Conference, Sbc2008. 87-88.  0.88
2008 Kung HF, Lieberman BP, Zhuang ZP, Oya S, Kung MP, Choi SR, Poessl K, Blankemeyer E, Hou C, Skovronsky D, Kilbourn M. In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine. Nuclear Medicine and Biology. 35: 825-37. PMID 19026944 DOI: 10.1016/j.nucmedbio.2008.08.004  0.88
2008 Li X, Jung YW, Snyder SE, Blair J, Sherman PS, Desmond T, Frey KA, Kilbourn MR. 5-tert-Butyl-2-(4′-[18F]fluoropropynylphenyl)-1,3-dithiane oxides: potential new GABAA receptor radioligands Nuclear Medicine and Biology. 35: 549-559. PMID 18589299 DOI: 10.1016/j.nucmedbio.2007.08.003  0.88
2008 Kung MP, Hou C, Lieberman BP, Oya S, Ponde DE, Blankemeyer E, Skovronsky D, Kilbourn MR, Kung HF. In vivo imaging of β-cell mass in rats using 18F-FP-(+)- DTBZ: A potential PET ligand for studying diabetes mellitus Journal of Nuclear Medicine. 49: 1171-1176. PMID 18552132 DOI: 10.2967/jnumed.108.051680  0.88
2008 Kilbourn MR, Butch E, Desmond T, Sherman P, Frey K. Dopamine depletion increases in vivo [11C]DTBZ binding in awake rat brain Neuroimage. 41: T54. DOI: 10.1016/j.neuroimage.2008.04.228  0.52
2007 Kilbourn MR, Ma B, Butch ER, Quesada C, Sherman PS. Anesthesia increases in vivo N-([18F]fluoroethyl)piperidinyl benzilate binding to the muscarinic cholinergic receptor Nuclear Medicine and Biology. 34: 479-482. PMID 17591547 DOI: 10.1016/j.nucmedbio.2007.04.008  0.88
2007 Scott PJH, Kilbourn MR. Determination of residual Kryptofix 2.2.2 levels in [18F]-labeled radiopharmaceuticals for human use Applied Radiation and Isotopes. 65: 1359-1362. PMID 17582776 DOI: 10.1016/j.apradiso.2007.04.020  0.88
2007 Kung MP, Hou C, Goswami R, Ponde DE, Kilbourn MR, Kung HF. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters Nuclear Medicine and Biology. 34: 239-246. PMID 17383573 DOI: 10.1016/j.nucmedbio.2006.12.005  0.88
2007 Kilbourn MR, Hockley B, Lee L, Hou C, Goswami R, Ponde DE, Kung MP, Kung HF. Pharmacokinetics of [18F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain Nuclear Medicine and Biology. 34: 233-237. PMID 17383572 DOI: 10.1016/j.nucmedbio.2007.01.007  0.88
2007 Eckelman WC, Kilbourn MR, Joyal JL, Labiris R, Valliant JF. Justifying the number of animals for each experiment. Nuclear Medicine and Biology. 34: 229-32. PMID 17383571 DOI: 10.1016/j.nucmedbio.2007.01.005  0.88
2007 Greenwald M, Johanson CE, Bueller J, Chang Y, Moody DE, Kilbourn M, Koeppe R, Zubieta JK. Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices. Biological Psychiatry. 61: 101-10. PMID 16950210 DOI: 10.1016/j.biopsych.2006.04.043  0.88
2007 Kilbourn M, Hockley B, Lee L, Hou C, Goswami R, Ponde D, Kung MP, Kung H. Fluorine-18 labeled dihydrotetrabenazine (DTBZ) derivatives for PET imaging of VMAT2 in the brain Journal of Cerebral Blood Flow and Metabolism. 27: PP10-06U.  0.88
2006 Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. Imaging butyrylcholinesterase activity in Alzheimer's disease. Annals of Neurology. 60: 746. PMID 17192935 DOI: 10.1002/ana.21023  0.88
2006 Simpson NR, Souza F, Witkowski P, Maffei A, Raffo A, Herron A, Kilbourn M, Jurewicz A, Herold K, Liu E, Hardy MA, Van Heertum R, Harris PE. Visualizing pancreatic beta-cell mass with [11C]DTBZ. Nuclear Medicine and Biology. 33: 855-64. PMID 17045165 DOI: 10.1016/j.nucmedbio.2006.07.002  0.88
2006 Eckelman WC, Kilbourn MR, Mathis CA. Radiopharmaceutical space Nuclear Medicine and Biology. 33: 829. PMID 17045161 DOI: 10.1016/j.nucmedbio.2006.07.005  0.88
2006 Goswami R, Ponde DE, Kung MP, Hou C, Kilbourn MR, Kung HF. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters Nuclear Medicine and Biology. 33: 685-694. PMID 16934687 DOI: 10.1016/j.nucmedbio.2006.05.006  0.88
2006 Eckelman WC, Kilbourn MR, Mathis CA. Discussion of targeting proteins in vivo: in vitro guidelines Nuclear Medicine and Biology. 33: 449-451. PMID 16720235 DOI: 10.1016/j.nucmedbio.2006.03.008  0.88
2006 Souza F, Simpson N, Raffo A, Saxena C, Maffei A, Hardy M, Kilbourn M, Goland R, Leibel R, Mann JJ, Van Heertum R, Harris PE. Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model. The Journal of Clinical Investigation. 116: 1506-13. PMID 16710474 DOI: 10.1172/JCI27645  0.88
2006 Johanson CE, Frey KA, Lundahl LH, Keenan P, Lockhart N, Roll J, Galloway GP, Koeppe RA, Kilbourn MR, Robbins T, Schuster CR. Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology. 185: 327-38. PMID 16518646 DOI: 10.1007/s00213-006-0330-6  0.88
2006 Bohnen NI, Albin RL, Koeppe RA, Wernette KA, Kilbourn MR, Minoshima S, Frey KA. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 26: 1198-212. PMID 16421508 DOI: 10.1038/sj.jcbfm.9600276  0.88
2006 Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses. Annals of Neurology. 59: 13-20. PMID 16278840 DOI: 10.1002/ana.20672  0.88
2005 Ma B, Hankenson KD, Dennis JE, Caplan AI, Goldstein SA, Kilbourn MR. A simple method for stem cell labeling with fluorine 18 Nuclear Medicine and Biology. 32: 701-705. PMID 16243645 DOI: 10.1016/j.nucmedbio.2005.04.018  0.88
2005 Nabulsi NB, Smith DE, Kilbourn MR. [11C]Glycylsarcosine: synthesis and in vivo evaluation as a PET tracer of PepT2 transporter function in kidney of PepT2 null and wild-type mice. Bioorganic & Medicinal Chemistry. 13: 2993-3001. PMID 15781409 DOI: 10.1016/j.bmc.2005.02.002  0.88
2005 Shao X, Koeppe RA, Butch ER, Kilbourn MR, Snyder SE. Evaluation of 18F-labeled acetylcholinesterase substrates as PET radiotracers Bioorganic and Medicinal Chemistry. 13: 869-875. PMID 15653352 DOI: 10.1016/j.bmc.2004.10.034  0.88
2004 Parrott AC, Fantegrossi WE, Woods JH, Winger G, Kilbourn M, Sherman P, Woolverton WL, Yuan J, Hatzidimitriou G, Ricaurte GA. MDMA and the loss of reinforcement in Fantegrossi et al (2004) (multiple letters) Neuropsychopharmacology. 29: 1940-1942. PMID 15383828 DOI: 10.1038/sj.npp.1300538  0.88
2004 Kilbourn MR, Kemmerer ES, Desmond TJ, Sherman PS, Frey KA. Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain Experimental Neurology. 188: 387-390. PMID 15246838 DOI: 10.1016/j.expneurol.2004.05.001  0.88
2004 Kilbourn MR. Long-term reproducibility of in vivo measures of specific binding of radioligands in rat brain Nuclear Medicine and Biology. 31: 591-595. PMID 15219277 DOI: 10.1016/j.nucmedbio.2004.02.003  0.88
2004 Ma B, Sherman PS, Moskwa JE, Koeppe RA, Kilbourn MR. Sensitivity of [11C]N-methylpyrrolidinyl benzilate ([ 11C]NMPYB) to endogenous acetylcholine: PET imaging vs tissue sampling methods Nuclear Medicine and Biology. 31: 393-397. PMID 15093808 DOI: 10.1016/j.nucmedbio.2003.12.009  0.88
2004 Fantegrossi WE, Woolverton WL, Kilbourn M, Sherman P, Yuan J, Hatzidimitriou G, Ricaurte GA, Woods JH, Winger G. Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1270-81. PMID 15039771 DOI: 10.1038/sj.npp.1300442  0.88
2004 Jewett DM, Kilbourn MR. In vivo evaluation of new carfentanil-based radioligands for the mu opiate receptor Nuclear Medicine and Biology. 31: 321-325. PMID 15028244 DOI: 10.1016/j.nucmedbio.2003.10.009  0.88
2003 Zubieta JK, Ketter TA, Bueller JA, Xu Y, Kilbourn MR, Young EA, Koeppe RA. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Archives of General Psychiatry. 60: 1145-53. PMID 14609890 DOI: 10.1001/archpsyc.60.11.1145  0.88
2003 Kemmerer ES, Desmond TJ, Albin RL, Kilbourn MR, Frey KA. Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole. Experimental Neurology. 183: 81-6. PMID 12957491 DOI: 10.1016/S0014-4886(03)00096-7  0.88
2003 Albin RL, Koeppe RA, Bohnen NI, Nichols TE, Meyer P, Wernette K, Minoshima S, Kilbourn MR, Frey KA. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology. 61: 310-5. PMID 12913189 DOI: 10.1212/01.WNL.0000076181.39162.FC  0.88
2003 Greenwald MK, Johanson CE, Moody DE, Woods JH, Kilbourn MR, Koeppe RA, Schuster CR, Zubieta JK. Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 2000-9. PMID 12902992 DOI: 10.1038/sj.npp.1300251  0.88
2003 Shao X, Butch ER, Kilbourn MR, Snyder SE. N-[18F]fluoroethylpiperidinyl, N-[18F]fluoroethylpiperidinemethyl and N-[18F]fluoroethylpyrrolidinyl esters as radiotracers for acetylcholinesterase Nuclear Medicine and Biology. 30: 491-500. PMID 12831986 DOI: 10.1016/S0969-8051(03)00031-3  0.88
2003 Shao X, Lisi JM, Butch ER, Kilbourn MR, Snyder SE. N-methylpiperidinemethyl, N-methylpyrrolidyl and N-methylpyrrolidinemethyl esters as PET radiotracers for acetylcholinesterase activity Nuclear Medicine and Biology. 30: 293-302. PMID 12745021 DOI: 10.1016/S0969-8051(02)00438-9  0.88
2002 Skaddan MB, Jewett DM, Sherman PS, Kilbourn MR. (R)-N-[11C]methyl-3-pyrrolidyl benzilate, a high-affinity reversible radioligand for PET studies of the muscarinic acetylcholine receptor Synapse. 45: 31-37. PMID 12112411 DOI: 10.1002/syn.10079  0.88
2002 Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA, Stohler CS. mu-opioid receptor-mediated antinociceptive responses differ in men and women. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 5100-7. PMID 12077205  0.88
2002 Kilbourn MR, Sherman PS, Kuszpit K. In vivo measures of dopaminergic radioligands in the rat brain: Equilibrium infusion studies Synapse. 43: 188-194. PMID 11793424 DOI: 10.1002/syn.10039  0.88
2002 Jewett DM, Kilbourn MR. A convenient synthesis of [11C]paraquat and other [N-methyl-11C]bisquaternary ammonium compounds Journal of Labelled Compounds and Radiopharmaceuticals. 45: 281-289. DOI: 10.1002/jlcr.564  0.88
2001 Koeppe RA, Raffel DM, Snyder SE, Ficaro EP, Kilbourn MR, Kuhl DE. Dual-[11C]tracer single-acquisition positron emission tomography studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 21: 1480-92. PMID 11740210 DOI: 10.1097/00004647-200112000-00013  0.88
2001 Skaddan MB, Sherman PS, Kilbourn MR. The role of species-dependent metabolism in the regional brain retention of 18F-labeled muscarinic acetylcholine receptor ligands Nuclear Medicine and Biology. 28: 753-759. PMID 11578895 DOI: 10.1016/S0969-8051(01)00240-2  0.88
2001 Frey KA, Koeppe RA, Kilbourn MR. Imaging the vesicular monoamine transporter. Advances in Neurology. 86: 237-247. PMID 11553983  0.88
2001 Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA, Stohler CS. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science (New York, N.Y.). 293: 311-5. PMID 11452128 DOI: 10.1126/science.1060952  0.88
2001 Skaddan MB, Kilbourn MR, Snyder SE, Sherman PS. Acetylcholinesterase inhibition increases in vivo N-(2-[18F]fluoroethyl)-4-piperidyl benzilate binding to muscarinic acetylcholine receptors Journal of Cerebral Blood Flow and Metabolism. 21: 144-148. PMID 11176279  0.88
2001 Snyder SE, Gunupudi N, Sherman PS, Butch ER, Skaddan MB, Kilbourn MR, Koeppe RA, Kuhl DE. Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 21: 132-43. PMID 11176278 DOI: 10.1097/00004647-200102000-00004  0.88
2001 Zubieta JK, Koeppe RA, Frey KA, Kilbourn MR, Mangner TJ, Foster NL, Kuhl DE. Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET. Synapse (New York, N.Y.). 39: 275-87. PMID 11169777 DOI: 10.1002/1098-2396(20010315)39:4<275::AID-SYN1010>3.0.CO;2-3  0.88
2001 Zubieta JK, Taylor SF, Huguelet P, Koeppe RA, Kilbourn MR, Frey KA. Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biological Psychiatry. 49: 110-6. PMID 11164757 DOI: 10.1016/S0006-3223(00)00981-1  0.88
2001 Kozloff KM, Frankenburg EP, Solchaga LA, Smith-Adaline EA, Taylor JC, Lennon DP, Dennis JE, Gao J, Kilbourn MR, Caplan AI, Goldstein SA. Mobility of indium-labeled mesenchymal progenitor cells during augmentation of bone repair following distraction osteogenesis American Society of Mechanical Engineers, Bioengineering Division (Publication) Bed. 50: 695-696.  0.88
2000 Skaddan MB, Kilbourn MR, Snyder SE, Sherman PS, Desmond TJ, Frey KA. Synthesis, 18F-labeling, and biological evaluation of piperidyl and pyrrolidyl benzilates as in vivo ligands for muscarinic acetylcholine receptors Journal of Medicinal Chemistry. 43: 4552-4562. PMID 11087580 DOI: 10.1021/jm000305o  0.88
2000 Zubieta JK, Huguelet P, Ohl LE, Koeppe RA, Kilbourn MR, Carr JM, Giordani BJ, Frey KA. High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates. The American Journal of Psychiatry. 157: 1619-28. PMID 11007716 DOI: 10.1176/appi.ajp.157.10.1619  0.88
2000 Kuhl DE, Minoshima S, Frey KA, Foster NL, Kilbourn MR, Koeppe RA. Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex. Annals of Neurology. 48: 391-5. PMID 10976649 DOI: 10.1002/1531-8249(200009)48:3<391::AID-ANA17>3.0.CO;2-H  0.88
2000 Zubieta J, Greenwald MK, Lombardi U, Woods JH, Kilbourn MR, Jewett DM, Koeppe RA, Schuster CR, Johanson CE. Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 326-34. PMID 10942856 DOI: 10.1016/S0893-133X(00)00110-X  0.88
2000 Brown-Proctor C, Snyder SE, Sherman PS, Kilbourn MR. Synthesis and in vivo evaluation of (E)-N-[11C]methyl-4(3-pyridinyl)-3-butene-l-amine ([11C]metanicotine) as a nicotinic receptor radioligand Nuclear Medicine and Biology. 27: 415-418. PMID 10938478  0.88
2000 Bohnen NI, Koeppe RA, Meyer P, Ficaro E, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL. Decreased striatal monoaminergic terminals in Huntington disease. Neurology. 54: 1753-9. PMID 10802780 DOI: 10.1212/WNL.54.9.1753  0.88
2000 Kilbourn MR, Kuszpit K, Sherman P. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice Synapse. 35: 250-255. PMID 10657034 DOI: 10.1002/(SICI)1098-2396(20000315)35:4<250::AID-SYN2>3.0.CO;2-S  0.88
2000 Brown-Proctor C, Snyder SE, Sherman PS, Kilbourn MR. Synthesis and in vivo evaluation of (E)-N-[11C]Methyl-4-(3-pyridinyl)-3-butene-1-amine ([11C]metanicotine) as a nicotinic receptor radioligand Journal of Inorganic Biochemistry. 78: 415-418.  0.88
1999 Koeppe RA, Frey KA, Kuhl DE, Kilbourn MR. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 19: 1376-84. PMID 10598942 DOI: 10.1097/00004647-199912000-00011  0.88
1999 Koeppe RA, Frey KA, Snyder SE, Meyer P, Kilbourn MR, Kuhl DE. Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 19: 1150-63. PMID 10532640 DOI: 10.1097/00004647-199910000-00012  0.88
1999 Kilbourn MR, Sherman PS, Snyder SE. Simplified methods for in vivo measurement of acetylcholinesterase activity in rodent brain Nuclear Medicine and Biology. 26: 543-550. PMID 10473193 DOI: 10.1016/S0969-8051(98)00122-X  0.88
1999 Meyer P, Bohnen NI, Minoshima S, Koeppe RA, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome. Neurology. 53: 371-4. PMID 10430428 DOI: 10.1212/WNL.53.2.371  0.88
1999 Brown-Proctor C, Snyder SE, Sherman PS, Kilbourn MR. Synthesis and evaluation of 6-[11C]methoxy-3-[2[1-(phenylmethyl)-4- piperidinyl]ethyl]-1,2-benzisoxazole as an in vivo radioligand for acetylcholinesterase Nuclear Medicine and Biology. 26: 99-103. PMID 10096508 DOI: 10.1016/S0969-8051(98)00078-X  0.88
1999 Kuhl DE, Koeppe RA, Minoshima S, Snyder SE, Ficaro EP, Foster NL, Frey KA, Kilbourn MR. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology. 52: 691-9. PMID 10078712 DOI: 10.1212/WNL.52.4.691  0.88
1999 Snyder SE, Sherman PS, Desmond TJ, Frey KA, Kilbourn MR. (-)-6',7'-[11C]dihydroroten-12α-ol ((-)-[11C]DHROL) for in vivo measurement of mitochondrial complex I Journal of Labelled Compounds and Radiopharmaceuticals. 42: 641-652. DOI: 10.1002/(SICI)1099-1344(199907)42:7<641::AID-JLCR226>3.0.CO;2-Y  0.88
1999 Blair JB, Snyder SE, Sherman PS, Kilbourn MR. Synthesis and in vivo characteristics of substituted 5-tert-butyl-2-phenyl-2-[11C]methyl-dithiane oxides as potential PET imaging agents for the GABA(A) chloride ion channel Journal of Labelled Compounds and Radiopharmaceuticals. 42: S635-S637.  0.88
1999 Brown-Proctor C, Sherman PS, Kilbourn MR. Synthesis of an F-18 radiolabeled transition state analog inhibitor of acetylcholinesterase Journal of Labelled Compounds and Radiopharmaceuticals. 42: S632-S634.  0.88
1999 Jewett DM, Kilbourn MR. High performance extraction disks for the preparation of a PET agent: A fast synthesis of [11C]carfentanil Journal of Labelled Compounds and Radiopharmaceuticals. 42: S873-S874.  0.88
1999 Van Dort ME, Kilbourn MR, Jung YW, Sherman PS, Wieland DM. Synthesis and evaluation of (E)-(3-[I-125]iodoprop-2-enyl) ether derivatives of α- and β-dihydrotetrabenazine as possible radioligands for the neuronal vesicular monoamine transporter (VMAT2) Journal of Labelled Compounds and Radiopharmaceuticals. 42: S389-S391.  0.88
1999 Bryan TA, Snyder SE, Sherman PS, Kuhl DE, Kilbourn MR. Synthesis of a carbon-11 labelled pyrollidine ester as a potential in vivo substrate for acetylcholinesterase and butyrylcholinesterase Journal of Labelled Compounds and Radiopharmaceuticals. 42: S207-S209.  0.88
1998 Nguyen TB, Snyder SE, Kilbourn MR. Syntheses of carbon-11 labeled piperidine esters as potential in vivo substrates for acetylcholinesterase Nuclear Medicine and Biology. 25: 761-768. PMID 9863564 DOI: 10.1016/S0969-8051(98)00072-9  0.88
1998 Kilbourn MR, Nguyen TB, Snyder SE, Sherman P. N-[11C]methylpiperidine esters as acetylcholinesterase substrates: An in vivo structure-reactivity study Nuclear Medicine and Biology. 25: 755-760. PMID 9863563 DOI: 10.1016/S0969-8051(98)00071-7  0.88
1998 Snyder SE, Tluczek L, Jewett DM, Nguyen TB, Kuhl DE, Kilbourn MR. Synthesis of 1-[11C]methylpiperidin-4-yl propionate ([11C]PMP) for in vivo measurements of acetylcholinesterase activity. Nuclear Medicine and Biology. 25: 751-4. PMID 9863562 DOI: 10.1016/S0969-8051(98)00045-6  0.88
1998 Mulholland GK, Wieland DM, Kilbourn MR, Frey KA, Sherman PS, Carey JE, Kuhl DE. [18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses. Synapse (New York, N.Y.). 30: 263-74. PMID 9776130 DOI: 10.1002/(SICI)1098-2396(199811)30:3<263::AID-SYN4>3.0.CO;2-9  0.88
1998 Kilbourn MR, Sherman P, Abbott LC. Reduced MPTP neurotoxicity in striatum of the mutant mouse tottering Synapse. 30: 205-210. PMID 9723790 DOI: 10.1002/(SICI)1098-2396(199810)30:2<205::AID-SYN10>3.0.CO;2-0  0.88
1998 Frey KA, Wieland DM, Kilbourn MR. Imaging of monoaminergic and cholinergic vesicular transporters in the brain Advances in Pharmacology (San Diego, Calif.). 42: 269-272. PMID 9327896 DOI: 10.1016/S1054-3589(08)60745-0  0.88
1998 Kieburtz K, Frey K, Albin R, Marek K, Bates G, Aylward E, Guttman M, Rouleau G, Baehr M, Pahwa R, Lyons KE, Wilkinson SB, Kieltyka J, Koller WC, Bertoni JM, ... ... Kilbourn MR, et al. Twelfth Annual Symposia on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Etiology, Pathogenesis, and Treatment of Huntington's Disease, Queen Elizabeth Hotel, Montreal, Canada, 18 October 1998 Movement Disorders. 13: 858-863. DOI: 10.1002/mds.870130522  0.88
1997 Kilbourn MR. In vivo radiotracers for vesicular neurotransmitter transporters Nuclear Medicine and Biology. 24: 615-619. PMID 9352531 DOI: 10.1016/S0969-8051(97)00101-7  0.88
1997 Koeppe RA, Frey KA, Kume A, Albin R, Kilbourn MR, Kuhl DE. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 919-31. PMID 9307605 DOI: 10.1097/00004647-199709000-00001  0.88
1997 Kilbourn MR, Charalambous A, Frey KA, Sherman P, Higgins DS, Greenamyre JT. Intrastriatal neurotoxin injections reduce in vitro and in vivo binding of radiolabeled rotenoids to mitochondrial complex I. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 265-72. PMID 9119899 DOI: 10.1097/00004647-199703000-00003  0.88
1997 Kilbourn MR, Lee LC, Heeg MJ, Jewett DM. Absolute configuration of (+)-α-dihydrotetrabenazine, an active metabolite of tetrabenazine Chirality. 9: 59-62. PMID 9094204 DOI: 10.1002/(SICI)1520-636X(1997)9:1<59::AID-CHIR11>3.0.CO;2-P  0.88
1997 Jewett DM, Kilbourn MR, Lee LC. A simple synthesis of [11C]dihydrotetrabenazine (DTBZ) Nuclear Medicine and Biology. 24: 197-199. PMID 9089713 DOI: 10.1016/S0969-8051(96)00213-2  0.88
1997 Kilbourn MR. Time-dependent recovery of in vivo binding sites after drug dosing: A method for radiotracer evaluation Nuclear Medicine and Biology. 24: 115-118. PMID 9080483 DOI: 10.1016/S0969-8051(96)00179-5  0.88
1996 Gilman S, Frey KA, Koeppe RA, Junck L, Little R, Vander Borght TM, Lohman M, Martorello S, Lee LC, Jewett DM, Kilbourn MR. Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography. Annals of Neurology. 40: 885-92. PMID 9007093 DOI: 10.1002/ana.410400610  0.88
1996 Frey KA, Koeppe RA, Kilbourn MR, Vander Borght TM, Albin RL, Gilman S, Kuhl DE. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Annals of Neurology. 40: 873-84. PMID 9007092 DOI: 10.1002/ana.410400609  0.88
1996 Koeppe RA, Frey KA, Vander Borght TM, Karlamangla A, Jewett DM, Lee LC, Kilbourn MR, Kuhl DE. Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 16: 1288-99. PMID 8898703 DOI: 10.1097/00004647-199611000-00025  0.88
1996 Bormans G, Sherman P, Snyder SE, Kilbourn MR. Synthesis of carbon-11- and fluorine-18-labeled 1-methyl-4-piperidyl-4'-fluorobenzoate and their biodistribution in mice. Nuclear Medicine and Biology. 23: 513-7. PMID 8832709 DOI: 10.1016/0969-8051(96)00033-9  0.88
1996 Kilbourn MR, Frey KA, Vander Borght T, Sherman PS. Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters Nuclear Medicine and Biology. 23: 467-471. PMID 8832701 DOI: 10.1016/0969-8051(96)00023-6  0.88
1996 Kilbourn MR, Snyder SE, Sherman PS, Kuhl DE. In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdin-4-yl propionate ([11C]PMP). Synapse (New York, N.Y.). 22: 123-31. PMID 8787128 DOI: 10.1002/(SICI)1098-2396(199602)22:2<123::AID-SYN5>3.0.CO;2-F  0.88
1996 Frey KA, Minoshima S, Koeppe RA, Kilbourn MR, Berger KL, Kuhl DE. Stereotaxic summation analysis of human cerebral benzodiazepine binding maps. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 16: 409-17. PMID 8621745 DOI: 10.1097/00004647-199605000-00007  0.88
1996 Lee LC, Borght TV, Sherman PS, Frey KA, Kilbourn MR. In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter Journal of Medicinal Chemistry. 39: 191-196. PMID 8568807 DOI: 10.1021/jm950117b  0.88
1995 Vander Borght T, Kilbourn M, Desmond T, Kuhl D, Frey K. The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. European Journal of Pharmacology. 294: 577-83. PMID 8750721 DOI: 10.1016/0014-2999(95)00594-3  0.88
1995 Vander Borght TM, Sima AA, Kilbourn MR, Desmond TJ, Kuhl DE, Frey KA. [3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity. Neuroscience. 68: 955-62. PMID 8577387 DOI: 10.1016/0306-4522(95)00167-H  0.88
1995 Vander Borght TM, Kilbourn MR, Koeppe RA, DaSilva JN, Carey JE, Kuhl DE, Frey KA. In vivo imaging of the brain vesicular monoamine transporter. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 36: 2252-60. PMID 8523116  0.88
1995 Van Dort ME, Jung YW, Sherman PS, Kilbourn MR, Wieland DM. Fluorine for hydroxy substitution in biogenic amines: Asymmetric synthesis and biological evaluation of fluorine-18-labeled β-fluorophenylalkylamines as model systems Journal of Medicinal Chemistry. 38: 810-815. PMID 7877146  0.88
1995 Charalambous A, Mangner TJ, Kilbourn MR. Synthesis of (2-[11C]methoxy)rotenone, a marker of mitochondrial complex I activity Nuclear Medicine and Biology. 22: 65-69. PMID 7735172 DOI: 10.1016/0969-8051(94)00075-U  0.88
1995 Mulholland GK, Kilbourn MR, Sherman P, Carey JE, Frey KA, Koeppe RA, Kuhl DE. Synthesis, in vivo biodistribution and dosimetry of [11C]N-methylpiperidyl benzilate ([11C]NMPB), a muscarinic acetylcholine receptor antagonist. Nuclear Medicine and Biology. 22: 13-7. PMID 7735163 DOI: 10.1016/0969-8051(94)00082-U  0.88
1995 Snyder SE, Kume A, Jung YW, Connor SE, Sherman PS, Albin RL, Wieland DM, Kilbourn MR. Synthesis of carbon-11-, fluorine-18-, and iodine-125-labeled GABAA-gated chloride ion channel blockers: substituted 5-tert-butyl-2-phenyl-1,3-dithianes and -dithiane oxides. Journal of Medicinal Chemistry. 38: 2663-71. PMID 7629805  0.88
1995 Kilbourn MR, Sherman PS, Abbott LC. Mutant mouse strains as models for in vivo radiotracer evaluations: [11C]methoxytetrabenazine ([11C]MTBZ) in Tottering mice Nuclear Medicine and Biology. 22: 565-567. PMID 7581164 DOI: 10.1016/0969-8051(95)00005-I  0.88
1995 Charalambous A, Tluczek L, Frey KA, Higgins DS, Greenamyre TJ, Kilbourn MR. Synthesis and biological evaluation in mice of (2-[11C]methoxy)-6',7'-dihydrorotenol, a second generation rotenoid for marking mitochondrial complex I activity. Nuclear Medicine and Biology. 22: 491-6. PMID 7550026 DOI: 10.1016/0969-8051(94)00129-8  0.88
1994 Dasilva JN, Carey JE, Sherman PS, Pisani TJ, Kilbourn MR. Characterization of [11C]tetrabenazine as an in vivo radioligand for the vesicular monoamine transporter Nuclear Medicine and Biology. 21: 151-156. PMID 9234277 DOI: 10.1016/0969-8051(94)90003-5  0.88
1994 Koeppe RA, Frey KA, Mulholland GK, Kilbourn MR, Buck A, Lee KS, Kuhl DE. [11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 14: 85-99. PMID 8263062 DOI: 10.1038/jcbfm.1994.13  0.88
1994 Kilbourn MR. [11C]NNC 12-0722 or [18F]GBR 13119: Just what is "better"? European Journal of Nuclear Medicine. 21: 695. PMID 7957357 DOI: 10.1007/BF00285593  0.88
1994 Charalambous A, Mangner TJ, Kilbourn MR. Synthesis of (N-[11C]methyl)Y-29794, a competitive inhibitor of prolyl endopeptidase Journal of Labelled Compounds and Radiopharmaceuticals. 34: 499-504. DOI: 10.1002/jlcr.2580340602  0.88
1994 Van Dort ME, Jung YW, Kilbourn MR, Wieland DM. Biogenic benzyl-[18F]fluorides: (1s,2s)-1-Desoxy-1-[18F]fluoro-meta- hydroxyephedrine for mapping cardiac sympathetic neurons Journal of Labelled Compounds and Radiopharmaceuticals. 35: 117-119.  0.88
1994 Scripko JG, Huang CC, Kilbourn MR. Synthesis of [Carbonyl-11C]CI-977, a potent κ-opioid receptor agonist Journal of Labelled Compounds and Radiopharmaceuticals. 35: 141.  0.88
1994 Kilbourn MR, Norton D, Moskwa J, Mangner T, Viola J, O'Donnell T, Palmicri D, Driscoll M, Kuhl DE. High-level production and use of carbon-11: A strategy for containment of stack emissions Journal of Labelled Compounds and Radiopharmaceuticals. 35: 251.  0.88
1994 Snyder SE, Kilbourn MR. Synthesis of [18F]2-(4-fluorophenyl)-1,3-dithianes as potential PET imaging agents for the GABA(A) chloride ion channel Journal of Labelled Compounds and Radiopharmaceuticals. 35: 510-511.  0.88
1994 Van Dort ME, Kilbourn MR, Mangner TJ. Synthesis of N-{N-[4-(4-{N 11C]methylamino}phenyl)butyryl]-L-prolyl}pyrrolidine: A potential radiotracer for prolyl endopeptidase Journal of Labelled Compounds and Radiopharmaceuticals. 34: 447-452.  0.88
1994 Charalambous A, Mangner TJ, Frey KA, Greenamyre TJ, Kilbourn MR. Synthesis of [11C]rotenone and preliminary biodistribution studies in mice and monkey Journal of Labelled Compounds and Radiopharmaceuticals. 35: 287-289.  0.88
1993 Kilbourn MR, DaSilva JN, Frey KA, Koeppe RA, Kuhl DE. In vivo imaging of vesicular monoamine transporters in human brain using [11C]tetrabenazine and positron emission tomography. Journal of Neurochemistry. 60: 2315-8. PMID 8492135 DOI: 10.1111/j.1471-4159.1993.tb03521.x  0.88
1993 DaSilva JN, Kilbourn MR, Mangner TJ. Synthesis of [11C]tetrabenazine, a vesicular monoamine uptake inhibitor, for PET imaging studies Applied Radiation and Isotopes. 44: 673-676. PMID 8472029 DOI: 10.1016/0969-8043(93)90130-3  0.88
1993 DaSilva JN, Kilbourn MR, Domino EF. In vivo imaging of monoaminergic nerve terminals in normal and MPTP-lesioned primate brain using positron emission tomography (PET) and [11C]tetrabenazine. Synapse (New York, N.Y.). 14: 128-31. PMID 8332945 DOI: 10.1002/syn.890140205  0.88
1993 Chakraborty PK, Gildersleeve DL, Jewett DM, Toorongian SA, Kilbourn MR, Schwaiger M, Wieland DM. High yield synthesis of high specific activity R-(-)-[11C]epinephrine for routine PET studies in humans Nuclear Medicine and Biology. 20: 939-944. PMID 8298573 DOI: 10.1016/0969-8051(93)90094-B  0.88
1993 DaSilva JN, Kilbourn MR, Mangner TJ. Synthesis of a [11C]Methoxy derivative of α-Dihydrotetrabenazine: a radioligand for studying the vesicular monoamine transporter Applied Radiation and Isotopes. 44: 1487-1489. PMID 7903060 DOI: 10.1016/0969-8043(93)90103-H  0.88
1993 Mulholland GK, Jung YW, Wieland DM, Kilbourn MR, Kuhl DE. Synthesis of [18F]fluoroethoxy-benzovesamicol, A radiotracer for cholinergic neurons Journal of Labelled Compounds and Radiopharmaceuticals. 33: 583-591. DOI: 10.1002/jlcr.2580330704  0.88
1993 Hasan A, Knapp FF, Kilbourn MR, Buchsbaum DJ. New azomycin acyclonucleosides. Synthesis and biodistribution of radiohalogenated analogues in tumor-bearing mice [1] Journal of Heterocyclic Chemistry. 30: 1351-1355.  0.88
1993 Rengan R, Chakraborty PK, Kilbourn MR. Can we predict reactivity for aromatic nucleophilic substitution with [18F]fluoride ion? Journal of Labelled Compounds and Radiopharmaceuticals. 33: 563-572.  0.88
1992 Mulholland GK, Otto CA, Jewett DM, Kilbourn MR, Koeppe RA, Sherman PS, Petry NA, Carey JE, Atkinson ER, Archer S. Synthesis, rodent biodistribution, dosimetry, metabolism, and monkey images of carbon-11-labeled (+)-2 alpha-tropanyl benzilate: a central muscarinic receptor imaging agent. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 33: 423-30. PMID 1740713  0.88
1992 DaSilva JN, Kilbourn MR. In vivo binding of [11C]tetrabenazine to vesicular monoamine transporters in mouse brain Life Sciences. 51: 593-600. PMID 1640810 DOI: 10.1016/0024-3205(92)90228-H  0.88
1992 Daugherty A, Kilbourn MR, Dence CS, Sobel BE, Thorpe SR. Quantitative assessment of lipoprotein metabolism by positron emission tomography with an 18F-containing residualizing label Nuclear Medicine and Biology. 19: 411-416. PMID 1629030 DOI: 10.1016/0883-2897(92)90127-K  0.88
1992 Kilbourn MR, Sherman PS, Pisani T. Repeated reserpine administration reduces in vivo [18F]GBR 13119 binding to the dopamine uptake site European Journal of Pharmacology. 216: 109-112. PMID 1526249 DOI: 10.1016/0014-2999(92)90216-Q  0.88
1992 Kilbourn MR. Shades of grey: Radiopharmaceutical chemistry in the 1990s and beyond Nuclear Medicine and Biology. 19: 603-606. PMID 1522014 DOI: 10.1016/0883-2897(92)90093-E  0.88
1992 Van Dort ME, Kilbourn MR, Chakraborty PK, Richfield EK, Gildersleeve DL, Wieland DM. Iodine-125 and fluorine-18 labeled aryl-1,4-dialkylpiperazines: potential radiopharmaceuticals for in vivo study of the dopamine uptake system. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 43: 671-80. PMID 1325425 DOI: 10.1016/0883-2889(92)90039-H  0.88
1992 Kilbourn MR. Pet and drug development: Examples from drugs affecting neurotransmitter reuptake systems International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology. 19: 135. DOI: 10.1016/0883-2897(92)90246-U  0.4
1991 Otsuka FL, Welch MJ, Kilbourn MR, Dence CS, Dilley WG, Wells SA. Antibody fragments labeled with fluorine-18 and gallium-68: In vivo comparison with indium-111 and iodine-125-labeled fragments Nuclear Medicine and Biology. 18: 813-816. PMID 1787093 DOI: 10.1016/0883-2897(91)90023-E  0.88
1991 Kilbourn MR, Mulholland GK, Sherman PS, Pisani T. In vivo binding of the dopamine uptake inhibitor [18F]GBR 13119 in MPTP-treated C57BL/6 mice Nuclear Medicine and Biology. 18: 803-806. PMID 1787091 DOI: 10.1016/0883-2897(91)90021-C  0.88
1991 Chakraborty PK, Kilbourn MR. [18F]fluorination/decarbonylation: New route to aryl [18F]fluorides International Journal of Radiation Applications and Instrumentation. Part. 42: 1209-1213. PMID 1668803 DOI: 10.1016/0883-2889(91)90199-B  0.88
1991 Chakraborty PK, Kilbourn MR. Oxidation of substituted 4-fluorobenzaldehydes: Application to the no-carrier-added syntheses of 4-[18F]fluoroguaiacol and 4-[18F]fluorocatechol International Journal of Radiation Applications and Instrumentation. Part. 42: 673-681. PMID 1663098 DOI: 10.1016/0883-2889(91)90039-4  0.88
1991 Frey KA, Holthoff VA, Koeppe RA, Jewett DM, Kilbourn MR, Kuhl DE. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Annals of Neurology. 30: 663-72. PMID 1662476 DOI: 10.1002/ana.410300506  0.88
1991 Koeppe RA, Holthoff VA, Frey KA, Kilbourn MR, Kuhl DE. Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 11: 735-44. PMID 1651944 DOI: 10.1038/jcbfm.1991.130  0.88
1991 Kilbourn MR. Synthesis of [18F]flunarizine International Journal of Radiation Applications and Instrumentation. Part. 42: 109-111. PMID 1648032 DOI: 10.1016/0883-2889(91)90058-9  0.88
1991 Mulholland GK, Jung YW, Haka MS, Gildersleeve D, Van Dort M, Wieland DM, Kilbourn MR. Synthesis of carbon-11 labeled analogs of vesamicol, a potent inhibitor of vesicular uptake of acetylcholine Journal of Labelled Compounds and Radiopharmaceuticals. 30: 416.  0.88
1991 Kilbourn MR, Pavia MS, Gregor VE. Syntheses of fluorine-18 labeled inhibitors of GABA (γ-aminobutyric acid) reuptake Journal of Labelled Compounds and Radiopharmaceuticals. 30: 389.  0.88
1991 Mourad A, Kilbourn MR. [18F]Fluorination of heterocyclic rings: Syntheses of [18F]fluoropyridazines by nucleophilic substitution Journal of Labelled Compounds and Radiopharmaceuticals. 30: 140.  0.88
1991 Mulholland GK, Kilbourn MR, Moskwa JJ. Direct simultaneous production of [15O]water and [13N]ammonia or [18F]fluoride ion by 26 MeV proton bombardment of a double chamber water target Journal of Labelled Compounds and Radiopharmaceuticals. 30: 89.  0.88
1991 Kilbourn MR, Subramanian R. Synthesis of fluorine-18 labeled 1,1-difluoro-2,2-dichloroethyl aryl ethers by isotopic exchange Journal of Labelled Compounds and Radiopharmaceuticals. 30: 153.  0.88
1990 Toorongian SA, Mulholland GK, Jewett DM, Bachelor MA, Kilbourn MR. Routine production of 2-Deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin Nuclear Medicine and Biology. 17: 273-279. PMID 2341282 DOI: 10.1016/0883-2897(90)90052-3  0.88
1990 Kilbourn MR, Jung YW, Haka MS, Gildersleeve DL, Kuhl DE, Wieland DM. Mouse brain distribution of a carbon-11 labeled vesamicol derivative: presynaptic marker of cholinergic neurons. Life Sciences. 47: 1955-63. PMID 2266779 DOI: 10.1016/0024-3205(90)90408-J  0.88
1990 Kilbourn MR, Pavia MR, Gregor VE. Synthesis of fluorine-18 labeled GABA uptake inhibitors International Journal of Radiation Applications and Instrumentation. Part. 41: 823-828. PMID 2176190 DOI: 10.1016/0883-2889(90)90059-P  0.88
1990 Jewett DM, Toorongian SA, Bachelor MA, Kilbourn MR. Extraction of [18F]fluoride from [18O]water by a fast fibrous anion exchange resin International Journal of Radiation Applications and Instrumentation. Part. 41: 583-586. PMID 2163375 DOI: 10.1016/0883-2889(90)90044-H  0.88
1990 Ciliax BJ, Kilbourn MR, Haka MS, Penney JB. Imaging the dopamine uptake site with ex vivo [18F]GBR 13119 binding autoradiography in rat brain. Journal of Neurochemistry. 55: 619-23. PMID 2115074  0.88
1990 Mulholland GK, Kilbourn MR, Moskwa JJ. Direct simultaneous production of [15O]water and [13N]ammonia or [18F]fluoride ion by 26 MeV proton irradiation of a double chamber water target International Journal of Radiation Applications and Instrumentation. Part. 41: 1193-1199. PMID 1963419 DOI: 10.1016/0883-2889(90)90206-V  0.88
1990 Kilbourn MR, Subramanian R. Synthesis of fluorine-18 labeled 1,1-difluoro-2,2-dichloroethyl aryl ethers by 18F-for-19F exchange Journal of Labelled Compounds and Radiopharmaceuticals. 28: 1355-1361. DOI: 10.1002/jlcr.2580281202  0.88
1990 Haka MS, Kilbourn MR. Synthesis of [18F]GBR 12909, a dopamine reuptake inhibitor Journal of Labelled Compounds and Radiopharmaceuticals. 28: 793-799. DOI: 10.1002/jlcr.2580280708  0.88
1989 Perlmutter JS, Kilbourn MR, Welch MJ, Raichle ME. Non-steady-state measurement of in vivo receptor binding with positron emission tomography: "dose-response" analysis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 2344-52. PMID 2787394  0.88
1989 Kilbourn MR. Thiophenes as phenyl bio-isosteres: Application in radiopharmaceutical design. I. Dopamine uptake antagonists Nuclear Medicine and Biology. 16: 681-686. PMID 2613523  0.88
1989 Kilbourn MR, Carey JE, Koeppe RA, Haka MS, Hutchins GD, Sherman PS, Kuhl DE. Biodistribution, dosimetry, metabolism and monkey PET studies of [18F]GBR 13119. Imaging the dopamine uptake system in vivo. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 16: 569-76. PMID 2606712 DOI: 10.1016/0883-2897(89)90072-X  0.88
1989 Junck L, Olson JM, Ciliax BJ, Koeppe RA, Watkins GL, Jewett DM, McKeever PE, Wieland DM, Kilbourn MR, Starosta-Rubinstein S. PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Annals of Neurology. 26: 752-8. PMID 2557794 DOI: 10.1002/ana.410260611  0.88
1989 Haka MS, Kilbourn MR. Synthesis and regional mouse brain distribution of [11C]nisoxetine, a norepinephrine uptake inhibitor. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 16: 771-4. PMID 2533589 DOI: 10.1016/0883-2897(89)90160-8  0.88
1989 Kilbourn MR, Haka MS, Mulholland GK, Sherman PS, Pisani T. Regional brain distribution of [18F]GBR 13119, a dopamine uptake inhibitor, in CD-1 and C57BL/6 mice. European Journal of Pharmacology. 166: 331-4. PMID 2529129 DOI: 10.1016/0014-2999(89)90078-2  0.88
1989 Kilbourn MR. Thiophenes as phenyl bio-isosteres: Application in radiopharmaceutical design-I. Dopamine uptake antagonists International Journal of Radiation Applications and Instrumentation.. 16: 681-686. DOI: 10.1016/0883-2897(89)90138-4  0.88
1989 Haka MS, Kilbourn MR, Watkins GL, Toorongian SA. Aryltrimethylammonium trifluoromethanesulfonates as precursors to aryl [18F]fluorides: Improved synthesis of [18F]GBR-13119 Journal of Labelled Compounds and Radiopharmaceuticals. 27: 823-833.  0.88
1988 Kilbourn MR. In vivo binding of [18F]GBR 13119 to the brain dopamine uptake system Life Sciences. 42: 1347-1353. PMID 3352457 DOI: 10.1016/0024-3205(88)90163-4  0.88
1988 Welch MJ, Katzenellenbogen JA, Mathias CJ, Brodack JW, Carlson KE, Chi DY, Dence CS, Kilbourn MR, Perlmutter JS, Raichle ME. N-(3-[18F]fluoropropyl)-spiperone: the preferred 18F labeled spiperone analog for positron emission tomographic studies of the dopamine receptor. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 15: 83-97. PMID 3258305 DOI: 10.1016/0883-2897(88)90164-X  0.88
1988 Wieland DM, Kilbourn MR, Yang DJ, Laborde E, Gildersleeve DL, Van Dort ME, Pirat JL, Ciliax BJ, Young AB. NMDA receptor channels: labeling of MK-801 with iodine-125 and fluorine-18. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 39: 1219-25. PMID 2851002 DOI: 10.1016/0883-2889(88)90103-7  0.88
1988 Jewett DM, Toorongian SA, Mulholland GK, Watkins GL, Kilbourn MR. Multiphase extraction: Rapid phase-transfer of [18F]fluoride ion for nucleophilic radiolabeling reactions International Journal of Radiation Applications and Instrumentation. Part. 39: 1109-1111. PMID 2850283 DOI: 10.1016/0883-2889(88)90001-9  0.88
1988 Brodack JW, Dence CS, Kilbourn MR, Welch MJ. Robotic production of 2-deoxy-2[18F]fluoro-d-glucose: A routine method of synthesis using tetrabutylammonium [18F]fluoride International Journal of Radiation Applications and Instrumentation. Part. 39: 699-703. PMID 2844702 DOI: 10.1016/0883-2889(88)90060-3  0.88
1988 Brodack JW, Kilbourn MR, Welch MJ. Automated production of several positron-emitting radiopharmaceuticals using a single laboratory robot International Journal of Radiation Applications and Instrumentation. Part. 39: 689-698. PMID 2844701 DOI: 10.1016/0883-2889(88)90059-7  0.88
1988 Kilbourn MR, Haka MS. Synthesis of [18F]GBR13119, a presynaptic dopamine uptake antagonist. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 39: 279-82. PMID 2838432 DOI: 10.1016/0883-2889(88)90015-9  0.88
1988 Leonard Watkins G, Jewett DM, Keith Mulholland G, Kilbourn MR, Toorongian SA. A captive solvent method for rapid N-[11C]methylation of secondary amides: Application to the benzodiazepine, 4′-chlorodiazepam (RO5-4864) International Journal of Radiation Applications and Instrumentation. Part. 39: 441-444. DOI: 10.1016/0883-2889(88)90077-9  0.88
1987 Welch MJ, Chi DY, Mathias CJ, Kilbourn MR, Brodack JW, Katzenellenbogen JA. Biodistribution of N-alkyl and N-fluoroalkyl derivatives of spiroperidol; radiopharmaceuticals for PET studies of dopamine receptors. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 13: 523-6. PMID 3818316 DOI: 10.1016/0883-2897(86)90132-7  0.48
1987 Mathias CJ, Welch MJ, Kilbourn MR, Jerabek PA, Patrick TB, Raichle ME, Krohn KA, Rasey JS, Shaw DW. Radiolabeled hypoxic cell sensitizers: tracers for assessment of ischemia. Life Sciences. 41: 199-206. PMID 3600179 DOI: 10.1016/0024-3205(87)90494-2  0.88
1987 Perlmutter JS, Kilbourn MR, Raichle ME, Welch MJ. MPTP-induced up-regulation of in vivo dopaminergic radioligand-receptor binding in humans. Neurology. 37: 1575-9. PMID 3498914 DOI: 10.1212/WNL.37.10.1575  0.88
1987 Herscovitch P, Raichle ME, Kilbourn MR, Welch MJ. Positron emission tomographic measurement of cerebral blood flow and permeability-surface area product of water using [15O]water and [11C]butanol. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 7: 527-42. PMID 3498732 DOI: 10.1038/jcbfm.1987.102  0.88
1987 Mathias CJ, Welch MJ, Katzenellenbogen JA, Brodack JW, Kilbourn MR, Carlson KE, Kiesewetter DO. Characterization of the uptake of 16α-([18F]fluoro)-17β-estradiol in DMBA-induced mammary tumors Nuclear Medicine and Biology. 14: 15-25. PMID 3108199 DOI: 10.1016/0883-2897(87)90156-5  0.88
1987 Chi DY, Kilbourn MR, Katzenellenbogen JA, Brodack JW, Welch MJ. Synthesis of no-carrier-added N-([18F]fluoroalkyl)spiperone derivatives. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 37: 1173-80. PMID 3028983 DOI: 10.1016/0883-2889(86)90002-X  0.52
1987 Dae YC, Kilbourn MR, Katzenellenbogen JA, Welch MJ. A rapid and efficient method for the fluoroalkylation of amines and amides. Development of a method suitable for incorporation of the short-lived positron emitting radionuclide fluorine-18 Journal of Organic Chemistry. 52: 658-664.  0.88
1986 Perlmutter JS, Larson KB, Raichle ME, Markham J, Mintun MA, Kilbourn MR, Welch MJ. Strategies for in vivo measurement of receptor binding using positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 6: 154-69. PMID 3485640 DOI: 10.1038/jcbfm.1986.29  0.84
1986 Jerabek PA, Patrick TB, Kilbourn MR, Dischino DD, Welch MJ. Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 37: 599-605. PMID 3021662 DOI: 10.1016/0883-2889(86)90079-1  0.32
1986 Kilbourn MR, Welch MJ. Fluorine-18 labeled receptor based radiopharmaceuticals. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 37: 677-83. PMID 2876971 DOI: 10.1016/0883-2889(86)90261-3  0.6
1985 Welch MJ, Kilbourn MR, Green MA. Radiopharmaceuticals labeled with short-lived positron-emitting radionuclides. Radioisotopes. 34: 170-9. PMID 3892598 DOI: 10.3769/RADIOISOTOPES.34.3_170  0.48
1985 Kilbourn MR. Syntheses of carbon-11 labeled amino acids International Journal of Nuclear Medicine and Biology. 12: 345-348. DOI: 10.1016/S0047-0740(85)80001-2  0.32
1984 Welch MJ, Raichle ME, Kilbourn MR, Mintun MA. [18F]spiroperidol: a radiopharmaceutical for the in vivo study of the dopamine receptor. Annals of Neurology. 15: S77-8. PMID 6611130 DOI: 10.1002/ANA.410150714  0.88
1984 Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Annals of Neurology. 15: 217-27. PMID 6609679 DOI: 10.1002/ana.410150302  0.88
1984 Kilbourn MR, Dischino DD, Welch MJ. Synthesis of DL-[3-11C]phenylalanine. The International Journal of Applied Radiation and Isotopes. 35: 603-5. PMID 6469391 DOI: 10.1016/0020-708X(84)90103-0  0.48
1984 Kilbourn MR, Hood JT, Welch MJ. A simple 18O water target for 18F production. The International Journal of Applied Radiation and Isotopes. 35: 599-602. PMID 6469390 DOI: 10.1016/0020-708X(84)90102-9  0.6
1984 Landvatter SW, Kiesewetter DO, Kilbourn MR, Katzenellenbogen JA, Welch MJ. (2R*, 3S*)-1-[18F]fluoro-2,3-bis(4-hydroxyphenyl)pentane [( 18F]fluoronor-hexestrol), a positron-emitting estrogen that shows highly-selective, receptor-mediated uptake by target tissues in vivo. Life Sciences. 33: 1933-8. PMID 6316052 DOI: 10.1016/0024-3205(83)90678-1  0.72
1983 Welch MJ, Kilbourn MR, Mathias CJ, Mintun MA, Raichle ME. Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor. Life Sciences. 33: 1687-93. PMID 6633162 DOI: 10.1016/0024-3205(83)90725-7  0.84
1982 Kilbourn MR, McElvany KD, Welch MJ. A simple synthesis of bromine-77-labeled alkyl bromides. The International Journal of Applied Radiation and Isotopes. 33: 391-2. PMID 7095878 DOI: 10.1016/0020-708X(82)90156-9  0.4
1982 Kilbourn MR, Welch MJ. No-carrier-added synthesis of [1-11C]pyruvic acid. The International Journal of Applied Radiation and Isotopes. 33: 359-61. PMID 7095876 DOI: 10.1016/0020-708X(82)90149-1  0.8
1980 Katzenellenbogen JA, Kilbourn MR, Carlson KE. Photosensitive steroids as probes of estrogen receptor sites. Annals of the New York Academy of Sciences. 346: 18-30. PMID 6930181 DOI: 10.1111/j.1749-6632.1980.tb22088.x  0.64
Show low-probability matches.